マーケットレポート詳細
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
遺伝子検査サービスの世界市場規模は2022年の推計150億ドルから、2031年には315億ドルへと拡大、市場の平均年成長率は8.4%と予測されます。
当レポートでは、遺伝子検査サービスの市場予測-2031年、各種セグメント別市場分析(検査タイプ別、アプリケーション別、国地域別、等)、市場ドライバー、市場シェア、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
・市場規模(US$)
出生前検査
新生児スクリーニング
予測/予兆検査
ファーマコゲノミクス検査
その他
※(市場規模US$)
病院内検査室
診断ラボ
専門クリニック
その他
※(市場規模US$)
腫瘍学
感染症
自己免疫疾患
その他
※(市場規模US$)
北米
・米国、カナダ
欧州
・英国、ドイツ、フランス、スペイン、イタリア
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
南米
・ブラジル、メキシコ
・その他南米
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
市場のドライバー、障壁、機会
規制動向
市場シェア
競合状況
Laboratory Corporation of America Holdings
Quest Diagnostics Incorporated
Genomic Health, Inc.
NeoGenomics Laboratories, Inc.
Eurofins Scientific
Ambry Genetics
Illumina, Inc.
23andMe, Inc.
(全200頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Genetic Testing Services Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5.1. Regulatory Scenario by Region/Globally
5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
5.3. Technological Advancements
5.4. COVID-19 Impact Analysis
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2017 - 2031
6.3.1. Prenatal Testing
6.3.2. New Born Screening
6.3.3. Predictive & Presymptomatic Testing
6.3.4. Pharmacogenomic Testing
6.3.5. Others
6.4. Market Attractiveness Analysis, by Test Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Service Provider, 2017-2031
7.3.1. Hospital-based Laboratories
7.3.2. Diagnostic Laboratories
7.3.3. Specialty Clinics
7.3.4. Others
7.4. Market Attractiveness Analysis, by Service Provider
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
8.3.1. Oncology
8.3.2. Infectious Diseases
8.3.3. Autoimmune Diseases
8.3.4. Others
8.4. Market Attractiveness Analysis, by Application
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Test Type, 2017-2031
10.2.1. Prenatal Testing
10.2.2. New Born Screening
10.2.3. Predictive & Presymptomatic Testing
10.2.4. Pharmacogenomic Testing
10.2.5. Others
10.3. Market Value Forecast, by Service Provider, 2017-2031
10.3.1. Hospital-based Laboratories
10.3.2. Diagnostic Laboratories
10.3.3. Specialty Clinics
10.3.4. Others
10.4. Market Value Forecast, by Application, 2017-2031
10.4.1. Oncology
10.4.2. Infectious Diseases
10.4.3. Autoimmune Diseases
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Test Type
10.6.2. By Service Provider
10.6.3. By Application
10.6.4. By Country
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017-2031
11.2.1. Prenatal Testing
11.2.2. New Born Screening
11.2.3. Predictive & Presymptomatic Testing
11.2.4. Pharmacogenomic Testing
11.2.5. Others
11.3. Market Value Forecast, by Service Provider, 2017-2031
11.3.1. Hospital-based Laboratories
11.3.2. Diagnostic Laboratories
11.3.3. Specialty Clinics
11.3.4. Others
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Oncology
11.4.2. Infectious Diseases
11.4.3. Autoimmune Diseases
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Test Type
11.6.2. By Service Provider
11.6.3. By Application
11.6.4. By Country/Sub-region
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017-2031
12.2.1. Prenatal Testing
12.2.2. New Born Screening
12.2.3. Predictive & Presymptomatic Testing
12.2.4. Pharmacogenomic Testing
12.2.5. Others
12.3. Market Value Forecast, by Service Provider, 2017-2031
12.3.1. Hospital-based Laboratories
12.3.2. Diagnostic Laboratories
12.3.3. Specialty Clinics
12.3.4. Others
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Oncology
12.4.2. Infectious Diseases
12.4.3. Autoimmune Diseases
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Test Type
12.6.2. By Service Provider
12.6.3. By Application
12.6.4. By Country/Sub-region
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017-2031
13.2.1. Prenatal Testing
13.2.2. New Born Screening
13.2.3. Predictive & Presymptomatic Testing
13.2.4. Pharmacogenomic Testing
13.2.5. Others
13.3. Market Value Forecast, by Service Provider, 2017-2031
13.3.1. Hospital-based Laboratories
13.3.2. Diagnostic Laboratories
13.3.3. Specialty Clinics
13.3.4. Others
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Oncology
13.4.2. Infectious Diseases
13.4.3. Autoimmune Diseases
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Test Type
13.6.2. By Service Provider
13.6.3. By Application
13.6.4. By Country/Sub-region
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Test Type, 2017-2031
14.2.1. Prenatal Testing
14.2.2. New Born Screening
14.2.3. Predictive & Presymptomatic Testing
14.2.4. Pharmacogenomic Testing
14.2.5. Others
14.3. Market Value Forecast, by Service Provider, 2017-2031
14.3.1. Hospital-based Laboratories
14.3.2. Diagnostic Laboratories
14.3.3. Specialty Clinics
14.3.4. Others
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Oncology
14.4.2. Infectious Diseases
14.4.3. Autoimmune Diseases
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Test Type
14.6.2. By Service Provider
14.6.3. By Application
14.6.4. By Country/Sub-region
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Laboratory Corporation of America Holdings
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Service Provider Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Quest Diagnostics Incorporated
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Service Provider Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Genomic Health, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Service Provider Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. NeoGenomics Laboratories, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Service Provider Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Eurofins Scientific
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Service Provider Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Ambry Genetics
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Service Provider Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Illumina, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Service Provider Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. 23andMe, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Service Provider Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
Table 01: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 02: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 03: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 04: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Region, 2017-2032
Table 05: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Country, 2017-2032
Table 06: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 07: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 08: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 09: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
Table 10: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 11: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 12: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 13: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
Table 14: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 15: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 16: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 17: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
Table 18: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 19: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 20: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032
Table 21: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
Table 22: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032
Table 23: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032
Table 24: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032"
Figure 01: Global Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 02: Genetic Testing Services Market Value Share, by Test Type, 2022
Figure 03: Genetic Testing Services Market Value Share, by Service Provider, 2022
Figure 04: Genetic Testing Services Market Value Share, by Application, 2022
Figure 05: Global Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 06: Global Genetic Testing Services Market Revenue (US$ Mn), by Prenatal Testing, 2017-2032
Figure 07: Global Genetic Testing Services Market Revenue (US$ Mn), by New Born Screening, 2017-2032
Figure 08: Global Genetic Testing Services Market Revenue (US$ Mn), by Predictive & Presymptomatic Testing, 2017-2032
Figure 09: Global Genetic Testing Services Market Revenue (US$ Mn), by Pharmacogenomic Testing, 2017-2032
Figure 10: Global Genetic Testing Services Market Revenue (US$ Mn), by Others, 2017-2032
Figure 11: Global Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 12: Global Genetic Testing Services Market Revenue (US$ Mn), by Service Provider, 2017-2032
Figure 13: Global Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2017-2032
Figure 14: Global Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032
Figure 15: Global Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032
Figure 16: Global Genetic Testing Services Market Value Share Analysis, by Region, 2022 and 2032
Figure 17: Global Genetic Testing Services Market Attractiveness Analysis, by Region, 2023-2032
Figure 18: North America Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 19: North America Genetic Testing Services Market Value Share Analysis, by Country, 2022 and 2032
Figure 20: North America Genetic Testing Services Market Attractiveness Analysis, by Country, 2023-2032
Figure 21: North America Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 22: North America Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 23: North America Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032
Figure 24: North America Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032
Figure 25: North America Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032
Figure 26: North America Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032
Figure 27: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 28: Europe Genetic Testing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
Figure 29: Europe Genetic Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
Figure 30: Europe Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 31: Europe Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 32: Europe Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032
Figure 33: Europe Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032
Figure 34: Europe Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032
Figure 35: Europe Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032
Figure 36: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 37: Asia Pacific Genetic Testing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
Figure 38: Asia Pacific Genetic Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
Figure 39: Asia Pacific Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 40: Asia Pacific Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 41: Asia Pacific Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032
Figure 42: Asia Pacific Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032
Figure 43: Latin America Genetic Testing Services Market Value Share Analysis, by Indication, 2022 and 2032
Figure 44: Latin America Genetic Testing Services Market Attractiveness Analysis, Indication, 2023-2032
Figure 45: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032
Figure 46: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
Figure 47: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
Figure 48: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032
Figure 49: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032
Figure 50: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032
Figure 51: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032
Figure 52: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032
Figure 53: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032